Log in to save to my catalogue

Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review

Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2774897972

Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review

About this item

Full title

Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review

Publisher

United States: Elsevier Inc

Journal title

The American journal of emergency medicine, 2023-04, Vol.66, p.124-128

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

AbstractBackgroundCardiogenic shock (CS) is associated with high morbidity and mortality. In recent times, there is increasing interest in the role of angiotensin II in CS. We sought to systematically review the current literature on the use of angiotensin II in CS. MethodsPubMed, EMBASE, Medline, Web of Science, PubMed Central, and CINAHL database...

Alternative Titles

Full title

Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2774897972

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2774897972

Other Identifiers

ISSN

0735-6757

E-ISSN

1532-8171

DOI

10.1016/j.ajem.2023.01.050

How to access this item